Antiarrhythmic effects of vernakalant in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with short QT syndrome type 1 - Xu, Qiang; Huang, Xuemei; Meng, Zenghui; Li, Yingrui; Zhong, Rujia; Li, Xin; Cyganek, Lukas; El-Battrawy, Ibrahim; Akın, Ibrahim; Zhou, Xiao-Bo; Lan, Huan (Journal of cardiovascular development and disease, 2022)
Gesehen am 02.04.2024